Search

Search Results
Results 1101 - 1110 of 1128 for Diabetes Type II
  • The role of transcription factors in next-gen drug discovery
    White Paper - 26 Aug 2025
    Discover how transcription factors are revolutionizing drug discovery.
  • Trikafta
    Drug - 11 Aug 2025
    Consumer Medicine Information (CMI) about Trikafta intended for persons living in Australia.
  • Ataris
    Drug - 15 May 2025
    Consumer Medicine Information (CMI) about Ataris intended for persons living in Australia.
  • Contrave 8/90
    Drug - 28 Apr 2025
    Consumer Medicine Information (CMI) about Contrave 8/90 intended for persons living in Australia.
  • Enclomiphene in Clinical Practice: Mechanism, Efficacy, and Safety Consideration
    Life Sciences - 9 Apr 2025
    Enclomiphene citrate effectively treats male hypogonadism by boosting testosterone and preserving sperm production without the side effects of traditional TRT.
  • Abiraterone-Teva 250mg
    Drug - 10 Nov 2024
    Consumer Medicine Information (CMI) about Abiraterone-Teva 250mg intended for persons living in Australia.
  • Abiraterone-Teva 500mg
    Drug - 10 Nov 2024
    Consumer Medicine Information (CMI) about Abiraterone-Teva 500mg intended for persons living in Australia.
  • Coveram
    Drug - 2 May 2024
    Consumer Medicine Information (CMI) about Coveram intended for persons living in Australia.
  • Dicarz
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Dicarz intended for persons living in Australia.
  • What are ACE Inhibitors and Where are they Used?
    Health - 11 Sep 2023
    ACE inhibitors work by interfering with the body's renin-angiotensin-aldosterone system (RAAS) and are used to treat a variety of diseases.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback